Engineering the Recruitment of Phosphotyrosine Binding Domain-containing Adaptor Proteins Reveals Distinct Roles for RET Receptor-mediated Cell Survival*
暂无分享,去创建一个
[1] J. Milbrandt,et al. Critical and distinct roles for key RET tyrosine docking sites in renal development. , 2006, Genes & development.
[2] S. Eketjäll,et al. Distinct Turnover of Alternatively Spliced Isoforms of the RET Kinase Receptor Mediated by Differential Recruitment of the Cbl Ubiquitin Ligase* , 2005, Journal of Biological Chemistry.
[3] S. Bao,et al. The activation of Akt/PKB signaling pathway and cell survival , 2005, Journal of cellular and molecular medicine.
[4] M. Ichihara,et al. A Targeting Mutation of Tyrosine 1062 in Ret Causes a Marked Decrease of Enteric Neurons and Renal Hypoplasia , 2004, Molecular and Cellular Biology.
[5] N. Hynes,et al. Memo mediates ErbB2-driven cell motility , 2004, Nature Cell Biology.
[6] R. Crowder,et al. Tyrosine 981, a Novel Ret Autophosphorylation Site, Binds c-Src to Mediate Neuronal Survival* , 2004, Journal of Biological Chemistry.
[7] E. Graaff,et al. Enteric Nervous System Progenitors Are Coordinately Controlled by the G Protein-Coupled Receptor EDNRB and the Receptor Tyrosine Kinase RET , 2003, Neuron.
[8] Masahide Takahashi,et al. Role of Dok1 in Cell Signaling Mediated by RET Tyrosine Kinase* , 2002, The Journal of Biological Chemistry.
[9] Masahide Takahashi,et al. Novel Mechanism of Regulation of Rac Activity and Lamellipodia Formation by RET Tyrosine Kinase* , 2002, The Journal of Biological Chemistry.
[10] M. Takahashi,et al. The GDNF/RET signaling pathway and human diseases. , 2001, Cytokine & growth factor reviews.
[11] V. D’Agati,et al. Differential activities of the RET tyrosine kinase receptor isoforms during mammalian embryogenesis. , 2001, Genes & development.
[12] W. Birchmeier,et al. Novel p62dok family members, dok-4 and dok-5, are substrates of the c-Ret receptor tyrosine kinase and mediate neuronal differentiation , 2001, The Journal of cell biology.
[13] Masahide Takahashi,et al. Identification of SNT/FRS2 docking site on RET receptor tyrosine kinase and its role for signal transduction , 2001, Oncogene.
[14] D. Newgreen,et al. GDNF is a chemoattractant for enteric neural cells. , 2001, Developmental biology.
[15] G. D. Vita,et al. The insulin receptor substrate (IRS)-1 recruits phosphatidylinositol 3-kinase to Ret: evidence for a competition between Shc and IRS-1 for the binding to Ret , 2001, Oncogene.
[16] R. Scott,et al. Signaling Complexes and Protein-Protein Interactions Involved in the Activation of the Ras and Phosphatidylinositol 3-Kinase Pathways by the c-Ret Receptor Tyrosine Kinase* , 2000, The Journal of Biological Chemistry.
[17] S. Jhiang. The RET proto-oncogene in human cancers , 2000, Oncogene.
[18] M. Ichihara,et al. Characterization of intracellular signals via tyrosine 1062 in RET activated by glial cell line-derived neurotrophic factor , 2000, Oncogene.
[19] I. Lax,et al. FRS2 Proteins Recruit Intracellular Signaling Pathways by Binding to Diverse Targets on Fibroblast Growth Factor and Nerve Growth Factor Receptors , 2000, Molecular and Cellular Biology.
[20] S. R. Datta,et al. Cellular survival: a play in three Akts. , 1999, Genes & development.
[21] A. Weiss,et al. Induction of NF-κB by the Akt/PKB kinase , 1999, Current Biology.
[22] T. Pawson,et al. Re-engineering the target specificity of the insulin receptor by modification of a PTB domain binding site , 1999, Oncogene.
[23] S. Meakin,et al. The Signaling Adapter FRS-2 Competes with Shc for Binding to the Nerve Growth Factor Receptor TrkA , 1999, The Journal of Biological Chemistry.
[24] J. Milbrandt,et al. Gene Targeting Reveals a Critical Role for Neurturin in the Development and Maintenance of Enteric, Sensory, and Parasympathetic Neurons , 1999, Neuron.
[25] C. Eng. RET proto-oncogene in the development of human cancer. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[26] M. Goldfarb,et al. Novel Recognition Motif on Fibroblast Growth Factor Receptor Mediates Direct Association and Activation of SNT Adapter Proteins* , 1998, The Journal of Biological Chemistry.
[27] J. Olefsky,et al. Grb10 Interacts Differentially with the Insulin Receptor, Insulin-like Growth Factor I Receptor, and Epidermal Growth Factor Receptor via the Grb10 Src Homology 2 (SH2) Domain and a Second Novel Domain Located between the Pleckstrin Homology and SH2 Domains* , 1998, The Journal of Biological Chemistry.
[28] T. Pawson,et al. RET alternate splicing influences the interaction of activated RET with the SH2 and PTB domains of Shc, and the SH2 domain of Grb2 , 1997, Oncogene.
[29] C. Worby,et al. Glial Cell Line-derived Neurotrophic Factor Signals through the RET Receptor and Activates Mitogen-activated Protein Kinase* , 1996, The Journal of Biological Chemistry.
[30] N. Asai,et al. A Mutation at Tyrosine 1062 in MEN2A-Ret and MEN2B-Ret Impairs Their Transforming Activity and Association with Shc Adaptor Proteins* , 1996, The Journal of Biological Chemistry.
[31] Susan S. Taylor,et al. Mitogenic Signaling by Ret/ptc2 Requires Association with Enigma via a LIM Domain* , 1996, The Journal of Biological Chemistry.
[32] M. F. White,et al. Identification of residues that control specific binding of the Shc phosphotyrosine-binding domain to phosphotyrosine sites. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[33] G. Apell,et al. Affinity, Specificity, and Kinetics of the Interaction of the SHC Phosphotyrosine Binding Domain with Asparagine-X-X-Phosphotyrosine Motifs of Growth Factor Receptors (*) , 1996, The Journal of Biological Chemistry.
[34] J. Bos,et al. Ret receptor tyrosine kinase activates extracellular signal-regulated kinase 2 in SK-N-MC cells. , 1995, Oncogene.
[35] A. Petros,et al. Structure and ligand recognition of the phosphotyrosine binding domain of Shc , 1995, Nature.
[36] M. White,et al. PTB Domains of IRS-1 and Shc Have Distinct but Overlapping Binding Specificities (*) , 1995, The Journal of Biological Chemistry.
[37] C. Turck,et al. PTB domain binding to signaling proteins through a sequence motif containing phosphotyrosine. , 1995, Science.
[38] A. Craparo,et al. Phosphotyrosine-dependent interaction of SHC and insulin receptor substrate 1 with the NPEY motif of the insulin receptor via a novel non-SH2 domain , 1995, Molecular and cellular biology.
[39] T. Pawson,et al. A conserved amino-terminal Shc domain binds to phosphotyrosine motifs in activated receptors and phosphopeptides , 1995, Current Biology.
[40] al. et,et al. Activation of RET as a dominant transforming gene by germline mutations of MEN2A and MEN2B , 1995, Science.
[41] B. Margolis,et al. A region in Shc distinct from the SH2 domain can bind tyrosine-phosphorylated growth factor receptors. , 1994, The Journal of biological chemistry.
[42] Frank Costantini,et al. Defects in the kidney and enteric nervous system of mice lacking the tyrosine kinase receptor Ret , 1994, Nature.
[43] R. Frank. Spot-synthesis: an easy technique for the positionally addressable, parallel chemical synthesis on a membrane support , 1992 .
[44] H. Hiai,et al. Isolation of ret proto-oncogene cDNA with an amino-terminal signal sequence. , 1989, Oncogene.
[45] T. Iwamoto,et al. Cloning and expression of the ret proto-oncogene encoding a tyrosine kinase with two potential transmembrane domains. , 1988, Oncogene.